Buchumschlag

Possible new mechanisms of primary drug resistance in NSCLC with EGFR mutation treated with Osimertinib

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Lujing Shao, Tong Li, Xinyan Jia, Xinyu Zhang, Qi Li, Chunyan Dong
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	IUBMB Life
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Investigation through naphtho[2,3‐a]pyrene on mutated EGFR mediated autophagy in NSCLC: Cellular model system unleashing therapeutic potential
von: Nikhil Samarth, et al.
Veröffentlicht: (2024)

CircROBO2 Orchestrates Osimertinib Resistance Through miR ‐625‐5p/ PDGFB ‐Mediated MAPK Activation in Non‐Small Cell Lung Cancer
von: Miao He, et al.
Veröffentlicht: (2025)

Integrated multi‐omics and machine learning reveal a gefitinib resistance signature for prognosis and treatment response in lung adenocarcinoma
von: Dong Zhou, et al.
Veröffentlicht: (2024)

Neuroprotection and mechanisms of ginsenosides in nervous system diseases: Progress and perspectives
von: Li Zhou, et al.
Veröffentlicht: (2024)

Nano‐therapeutics: The upcoming nanomedicine to treat cancer
von: Hamda Khan, et al.
Veröffentlicht: (2024)

CDKN3 as a key regulator of G2M phase in triple‐negative breast cancer: Insights from multi‐transcriptomic analysis
von: Haodi Ma, et al.
Veröffentlicht: (2025)

Integration of Single‐Cell and Spatial Transcriptomics With Experimental Validation Uncovers Macrophage Diversity and Spatial Landscape in Carotid Atherosclerosis
von: Rongxing Qin, et al.
Veröffentlicht: (2026)

Histone demethylase LSD1 promotes castration‐resistant prostate cancer by causing widespread gene expression derangements
von: Haiying Li, et al.
Veröffentlicht: (2025)

Potential COVID‐19 remedies from repurposed drugs and herbal small RNAs
von: Yang Yang, et al.
Veröffentlicht: (2024)

Optimization of the chromium (Cr+6) reduction from waterways using chemically and bacterially treated agro‐waste
von: Jayeshkumar Ruparelia, et al.
Veröffentlicht: (2024)

POBS Relieves Antigen‐Induced Experimental S jögren's Disease by Regulating B Lymphocyte Subsets via CXCL13 / CXCR5 Signaling Pathway
von: Xiaosheng Lei, et al.
Veröffentlicht: (2026)

Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK–VEGF/MMPs signaling pathway
von: Li Tian, et al.
Veröffentlicht: (2024)

Cholesteryl ester transfer protein knock‐down in conjunction with a cholesterol‐depleting agent decreases tamoxifen resistance in breast cancer cells
von: Liang Gu, et al.
Veröffentlicht: (2024)

CRYAB is upregulated and predicts clinical prognosis in kidney renal clear cell carcinoma
von: Hao Ren, et al.
Veröffentlicht: (2025)

HucMSC extracellular vesicles increasing SATB 1 to activate the Wnt/β‐catenin pathway in 6‐OHDA‐induced Parkinson's disease model
von: Ying He, et al.
Veröffentlicht: (2024)

OTUD1 Relieves Coxsackievirus‐Induced Ferroptosis and Inflammation in Myocardial Cells by Stabilizing NRF2 and Inhibiting NF ‐ κB Signaling
von: Yanfei Chen, et al.
Veröffentlicht: (2026)

Delivery of AKT1 phospho‐forms to human cells reveals differential substrate selectivity
von: Tarana Siddika, et al.
Veröffentlicht: (2024)

Zinc finger protein 169 promotes tumor progress of hepatocellular cancer via up‐regulating cyclin‐dependent kinase 19
von: Chaoquan Hu, et al.
Veröffentlicht: (2025)

Punicalagin Targets FDX1 to Induce Cuproptosis for the Treatment of Gastric Cancer
von: Yuan‐yuan Fang, et al.
Veröffentlicht: (2026)

Discovery and Validation of a New Biomarker Integrating Ferroptosis and Glycolysis‐Related Genes in Bladder Cancer
von: Chenyang Wang, et al.
Veröffentlicht: (2025)

Modulation of PPAR‐α and PPAR‐γ Influences Cardiomyocyte Growth and Cardiac Remodeling
von: Qinkao Xuan, et al.
Veröffentlicht: (2025)

KGF secreted from HSCs activates PAK4/BMI1, promotes HCC stemness through PI3K/AKT pathway
von: Qinghua Li, et al.
Veröffentlicht: (2024)

The cellular localization and oncogenic or tumor suppressive effects of angiomiotin‐like protein 2 in tumor and normal cells
von: Huizhen Wang, et al.
Veröffentlicht: (2024)

Hederagenol improves multiple sclerosis by modulating Th17 cell differentiation
von: Dongsheng Guan, et al.
Veröffentlicht: (2024)

RING Finger Protein 4 (RNF4) Reduces Nonalcoholic Fatty Liver Disease Accumulation by Promoting the SUMOylation of HIF‐2α and Regulating the PPARα Signaling Pathway
von: Li Yang, et al.
Veröffentlicht: (2025)

Single‐Cell Profiling of the Microenvironment in High‐Risk Neuroblastoma
von: Yuxuan Xu, et al.
Veröffentlicht: (2025)

Enhancing the activation of T cells through anti‐CD3/CD28 magnetic beads by adjusting the antibody ratio
von: Yinuo Chen, et al.
Veröffentlicht: (2024)

Irisin alleviates the pyroptosis of β cells in T2DM by inhibiting NLRP3 inflammasome through regulating miR‐19b‐3p/SOCS3/STAT3 axis mediated autophagy
von: Jingjing Yang, et al.
Veröffentlicht: (2024)

PGAM1 Orchestrates Cell Cycle Progression, Glycolytic Reprogramming, and Immunosuppressive Microenvironment in Triple‐Negative Breast Cancer
von: Shunshun Zhang, et al.
Veröffentlicht: (2026)

Pyrimidine–triazole‐tethered tert‐butyl‐piperazine‐carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β‐catenin activation
von: Jie Yuan, et al.
Veröffentlicht: (2024)

The Synergic Inhibition of Wilforlide A With Cisplatin in Lung Cancer Is Mediated Through Caspase‐3 and NFκB Signaling
von: Zhonglu Peng, et al.
Veröffentlicht: (2025)

SNHG14 promotes triple‐negative breast cancer cell proliferation, invasion, and chemoresistance by regulating the ERK/MAPK signaling pathway
von: Bin Wang, et al.
Veröffentlicht: (2024)

Screening and experimental validation of diagnostic gene in ulcerative colitis with anti‐TNF‐α therapy
von: Yuan Chen, et al.
Veröffentlicht: (2024)

MiR‐3680‐3p is a novel biomarker for the diagnosis and prognosis of liver cancer and is involved in regulating the progression of liver cancer
von: Jie Tang, et al.
Veröffentlicht: (2024)

DYRK1A Overexpression Drives Muscle Wasting by Impeding Myogenesis via a USP7‐Axin1‐β‐Catenin Regulatory Axis in Mice
von: Mei Lu, et al.
Veröffentlicht: (2025)

Pan‐Cancer Analysis Identifies DIP2B as a Potential Biomarker That Inhibits Kidney Renal Clear Cell Carcinoma Progression
von: Yang Chen, et al.
Veröffentlicht: (2025)

CDCA4 / SERTAD1 / E2F1 Facilitates Lung Adenocarcinoma Progression by Inhibiting PINK1 /Parkin‐Mediated Mitophagy
von: Jianlong Tan, et al.
Veröffentlicht: (2025)

Enhanced HER2 status detection in breast and gastric cancers using surrogate DNA methylation markers
von: Yajie Hu, et al.
Veröffentlicht: (2025)

The up‐regulation of RIPK3 mediated by ac4C modification promotes oxidative stress‐induced granulosa cell senescence by inhibiting the Nrf2/HO‐1 pathway
von: Wanjun Zhang, et al.
Veröffentlicht: (2025)

LGMN as a Functionally Significant Prognostic and Immunoregulatory Biomarker in Glioma
von: Chenyi Nie, et al.
Veröffentlicht: (2025)